IMCR - Immunocore Holdings -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg ยท closes rebased to 100 at each year's first session
Ticker Details
Immunocore Holdings
IPO Date: February 5, 2021
Sector: Healthcare
Industry: Biotech
Market Cap: $1.53B
Activated in VL: True
Average Daily Range
Avg Daily Range: $1.00 | 2.49%
Avg Daily Range (30 D): $0.50 | 1.48%
Avg Daily Range (90 D): $0.55 | 1.69%
Institutional Daily Volume
Avg Daily Volume: .28M
Avg Daily Volume (30 D): .33M
Avg Daily Volume (90 D): .44M
Trade Size
Avg Trade Size (Sh.): 76
Avg Trade Size (Sh.) (30 D): 73
Avg Trade Size (Sh.) (90 D): 82
Institutional Trades
Total Institutional Trades: 2,306
Avg Institutional Trade: $1.63M
Avg Institutional Trade (30 D): $1.36M
Avg Institutional Trade (90 D): $1.37M
Avg Institutional Trade Volume: .04M
Avg Institutional Trades (Per Day): 2
Market Closing Trades
Avg Closing Trade: $1.41M
Avg Closing Trade (30 D): $1.04M
Avg Closing Trade (90 D): $1.09M
Avg Closing Volume: 33.9K
 
News
Sep 15, 2026 @ 3:22 PM
Immunocore Hits Enrollment Target in Kimmtrak Labe...
Source: Na
Sep 1, 2026 @ 11:00 AM
Immunocore to present at upcoming investor confere...
Source: Na
May 31, 2026 @ 12:00 PM
Immunocore presents updated Phase 1 data of brenet...
Source: Immunocore Holdings Plc
May 6, 2026 @ 11:00 AM
Immunocore reports first quarter financial results...
Source: Immunocore Holdings Plc
Apr 19, 2026 @ 10:00 PM
KIMMTRAK doubles the likelihood of being alive at ...
Source: Immunocore Holdings Plc
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-.36 $-.02 $.26
Diluted EPS $-.37 $-.02 $.25
Revenue $430.78M $115.93M $106.68M
Gross Profit $426.04M $114.84M $106.24M
Net Income / Loss $-18.07M $-.81M $12.97M
Operating Income / Loss $-22.58M $-3M $7.28M
Cost of Revenue $4.74M $1.09M $.43M
Net Cash Flow $-3.01M $32.25M $-15.03M
PE Ratio